Summary of major conclusions from the 6th International Workshop on Genotoxicity Testing (IWGT), Foz do Iguaçu, Brazil

Affiliations

• ¹ Novartis Institutes for BioMedical Research, Preclinical Safety, 4002 Basel, Switzerland. Electronic address: Hansjoerg.Martus@Novartis.com.
• ² Public Interest Incorporated Foundation BioSafety Research Center, Iwata, Japan.
• ³ National Institute of Health Sciences, Division of Genetics & Mutagenesis, 1-18-1 Kamiyoga, Setagaya-ku, Tokyo 158-8501, Japan.
• ⁴ Federal Institute for Drugs and Medical Devices (BfArM), Bonn, Germany.
• ⁵ Exponent, Inc., Center for Toxicology & Mechanistic Biology, Midland, MI 48640, USA.
• ⁶ Pharmaceutical Sciences, Roche Innovation Center, F Hoffmann-La Roche AG, CH 4070 Basel, Switzerland.
• ⁷ Office of Science Policy, Office of Research and Development, U.S. Environmental Protection Agency, Room 51134 RRB, 1200 Pennsylvania Avenue NW (8104R), Washington DC 20460-0001, USA.
• ⁸ Safety Research Laboratories, Mitsubishi Tanabe Pharma Co., Chiba 292-0818, Japan.
• ⁹ Kirkland Consulting, PO Box 79, Tadcaster LS24 0AS, UK.